Search Results - "CUTULI, B"

Hypofractionated whole breast irradiation (WBRT): Results and indications by Cutuli, B

“…Breast irradiation after breast-conserving surgery is essential for maximizing local control and overall survival. The increase of breast cancer (BC)…”
Get full text

Radiotherapy for breast cancer: which strategy in 2012? by Cutuli, B

“…Postoperative radiotherapy remains essential in breast cancer in 2012. After conserving surgery, it reduces local recurrence risks from 50 to 70%, both for…”
Get full text

EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants by Cardoso, M.J., Wyld, L., Rubio, I.T., Leidenius, M., Curigliano, G., Cutuli, B., Marotti, L., Biganzoli, L.

“…During the last two decades the number of breast implants used in aesthetic, oncologic and risk reducing surgery has increased substantially mainly due to the…”
Get full text

Quality indicators in breast cancer care by Rosselli Del Turco, M, Ponti, A, Bick, U, Biganzoli, L, Cserni, G, Cutuli, B, Decker, T, Dietel, M, Gentilini, O, Kuehn, T, Mano, M.P, Mantellini, P, Marotti, L, Poortmans, P, Rank, F, Roe, H, Scaffidi, E, van der Hage, J.A, Viale, G, Wells, C, Welnicka-Jaskiewicz, M, Wengstöm, Y, Cataliotti, L

“…Abstract To define a set of quality indicators that should be routinely measured and evaluated to confirm that the clinical outcome reaches the requested…”
Get full text

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases by Cutuli, B, Le-Nir, C. Cohen-Solal, Serin, D, Kirova, Y, Gaci, Z, Lemanski, C, De Lafontan, B, Zoubir, M, Maingon, P, Mignotte, H, Lara, C. Tunon de, Edeline, J, Penault-Llorca, F, Romestaing, P, Delva, C, Comet, B, Belkacemi, Y

“…Abstract Background Infiltrating MBC represents less than 1% of all male cancers. Our study details clinico-pathological features, treatments and prognostic…”
Get full text

Radiotherapy of breast cancer by Hennequin, C., Belkacémi, Y., Bourgier, C., Cowen, D., Cutuli, B., Fourquet, A., Hannoun-Lévi, J.-M., Pasquier, D., Racadot, S., Rivera, S.

“…Adjuvant radiotherapy is an essential component of the treatment of breast cancer. After conservative surgery for an infiltrating carcinoma, radiotherapy must…”
Get full text

Corrigendum to “About the French prohibition of textured breast implants: Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position” [Breast 46 (August 2019) 95–96] by Cardoso, M.J., Biganzoli, L., Rubio, I.T., Leidenius, M., Curigliano, G., Cutuli, B., Marotti, L., Kovacs, T., Wyld, L.

Get full text

Corrigendum to “EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants” [Breast 44 (April 2019) 90–93] by Cardoso, M.J., Wyld, L., Rubio, I.T., Leidenius, M., Curigliano, G., Cutuli, B., Marotti, L., Biganzoli, L.

Get full text

The Assisi Think Tank Meeting Survey of post-mastectomy radiation therapy in ductal carcinoma in situ: Suggestions for routine practice by Montero-Luis, A., Aristei, C., Meattini, I., Arenas, M., Boersma, L., Bourgier, C., Coles, C., Cutuli, B., Falcinelli, L., Kaidar-Person, O., Leonardi, M.C., Offersen, B., Marazzi, F., Rivera, S., Tagliaferri, L., Tombolini, V., Vidali, C., Valentini, V., Poortmans, P.

“…Risk factors for local recurrence after mastectomy in ductal carcinoma in situ (DCIS) emerged as a grey area during the second “Assisi Think Tank Meeting”…”
Get full text

Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study by Belkacémi, Y., Gligorov, J., Ozsahin, M., Marsiglia, H., De Lafontan, B., Laharie-Mineur, H., Aimard, L., Antoine, E.-C., Cutuli, B., Namer, M., Azria, D.

“…Trastuzumab (T) combined with chemotherapy has been recently shown to improve outcome in HER2-positive breast cancer (BC). The aim of this study was to…”
Get full text

About the French prohibition of textured breast implants: is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position by Cardoso, M.J., Biganzoli, L., Rubio, I.T., M, Leidenius, G, Curigliano, B, Cutuli, L, Marotti, Kovacs, T., Wyld, L.

Get full text

Breast cancer irradiation in elderly by Cutuli, B

“…In Western countries, about 25% of breast cancers (BC) occur in women older than 70 years old. Local control is a crucial step to cure disease, because…”
Get full text

Radiotherapy for invasive breast cancer: Guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence by Belkacémi, Y, Fourquet, A, Cutuli, B, Bourgier, C, Hery, M, Ganem, G, Marsiglia, H, Namer, M, Gligorov, J, Azria, D

“…Abstract Purpose While new strategies for the treatment of invasive breast cancer (BC) are emerging, radiotherapy (RT) modalities are still under debate. The…”
Get full text

440 Should all pre-invasive lesions be excised and irradiated? by Cutuli, B

Get full text

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience by Cutuli, B, Lemanski, C, Fourquet, A, de Lafontan, B, Giard, S, Meunier, A, Pioud-Martigny, R, Campana, F, Marsiglia, H, Lancrenon, S, Mery, E, Penault-Llorca, F, Fondrinier, E, Tunon de Lara, C

“…From March 2003 to April 2004, 77 physicians throughout France prospectively recruited 1289 ductal carcinoma in situ (DCIS) patients and collected data on…”
Get full text

Hypofractionated whole breast irradiation: Pro and cons by Cutuli, B, Fourquet, A

“…The continuous increase of breast cancer (BC) incidence, the logistic constraints of the protracted standard 5-week radiations regimen have led to test short…”
Get full text

Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences by Cutuli, B., Wiezzane, N., Palumbo, I., Barbieri, P., Guenzi, M., Huscher, A., Borghesi, S., Delva, C., Iannone, T., Vianello, E., Rosetto, M.-E., Aristei, C.

“…Ductal carcinoma in situ represents 15 to 20% of all breast cancers. Breast-conserving surgery and whole breast irradiation was performed in about 60% of the…”
Get full text

Radiothérapie des cancers du sein en 2012 : quelles stratégies ? by Cutuli, B.

“…La radiothérapie postopératoire conserve un rôle fondamental dans le cancer du sein en 2012. Après chirurgie conservatrice, elle réduit de 50 à 70 % le risque…”
Get full text

Adjuvant radiotherapy in the management of axillary node negative invasive breast cancer: A qualitative systematic review by Bourgier, C, Aimard, L, Bodez, V, Bollet, M.A, Cutuli, B, Franck, D, Hennequin, C, Kirova, Y.M, Azria, D

“…Abstract Purpose To actualize and to detail guidelines used in technical radiotherapy and indications for innovative radiation technologies in early axillary…”
Get full text

The impact of loco-regional radiotherapy on the survival of breast cancer patients by Cutuli, B

Get full text